The citrus industry is of great importance in Mexico, with an estimated production value of USD 2.4 billion and the potential to generate up to 28 million employees per year. Approximately 69,000 Mexican families depend on this sector. However, it is under serious threat from the disease known as Huanglongbing (HLB). The rapid spread of this disease has caused significant economic losses, impacted the livelihoods of citrus growers, and led to substantial job losses. Currently, HLB is not under control in Mexico, and as the management strategies applied have proven to be ineffective, yields have not been recovered to pre-HLB levels, and production costs have significantly increased. Therefore, it remains the most destructive citrus disease. This review paper describes the current situation of the disease, its economic and social impact, and the measures adopted for its management in Mexico. Future perspectives highlight advances in research based on new biotechnological tools as an eco-friendly management alternative. Practical suggestions to address HLB are also mentioned in our analysis.

Citrus commercial species are the most important fruit crops in the world; however, their cultivation is seriously threatened by the fast dispersion of emerging diseases, including Huanglongbing (HLB) citrus greening. HLB disease is vectored by psyllid vectors and associated with phloem-limited α-proteobacteria belonging to the Candidatus Liberibacter genus. Climatic change and trade globalization have led to the rapid spread of HLB from its origin center in Southeast Asia, causing a great economic impact in the main production areas, including East Asia (China), the Mediterranean basin, North America (the United States), and Latin America (Brazil and Mexico). Despite important advances to understand the HLB epidemiology, Candidatus Liberibacter genetics, psyllid vector control, the molecular citrus–Candidatus Liberibacter interaction, and the development of integral disease management strategies, the study areas have been mostly restricted to high-tech-producing countries. Thus, in this review, we provide an overview of the epidemiology, distribution, genetic diversity, management aspects, and omics analysis of HLB in Latin America, where this information to date is limited.